Covering the Cover Gastroenterology Anson W. Lowe, Richard H. Moseley  Gastroenterology  Volume 149, Issue 6, Pages 1295-1297 (November 2015) DOI: 10.1053/j.gastro.2015.09.034 Copyright © 2015 AGA Institute Terms and Conditions

Figure 1 IBS symptom severity (mean ± SD) in patients who completed the intervention. IBS symptom severity measured by IBS-SSS was reduced in both groups at the end of the intervention period (day 29) compared with baseline (P < .001 in both groups), whereas at day 14, the reduction in the IBS-SSS reached statistical significance in the low-FODMAP group (P = .002), with a trend in the same direction in the traditional IBS diet group (P = .051). No differences between the groups were detected. Gastroenterology 2015 149, 1295-1297DOI: (10.1053/j.gastro.2015.09.034) Copyright © 2015 AGA Institute Terms and Conditions

Figure 2 Percentage of cumulative risks (unbroken lines) and corresponding 95% confidence intervals (dotted lines) of colorectal cancer for African American carriers of (A) all MMR gene mutations and (B) mutations in MLH1 and MSH2 and AA SEER population-based data (dashed lines). Blue and red represent males and females, respectively. SEER, Surveillance, Epidemiology and End Results database. Gastroenterology 2015 149, 1295-1297DOI: (10.1053/j.gastro.2015.09.034) Copyright © 2015 AGA Institute Terms and Conditions